For research use only. Not for therapeutic Use.
MAO-B-IN-18（Cat No.:I041229）is a selective inhibitor of monoamine oxidase B (MAO-B), an enzyme that plays a critical role in the breakdown of neurotransmitters such as dopamine and serotonin in the brain. By inhibiting MAO-B, this compound helps to increase the levels of these neurotransmitters, potentially offering therapeutic benefits in the treatment of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease. MAO-B-IN-18 is used in research to explore its efficacy in modulating neurochemistry and its potential as a neuroprotective agent, aiming to improve cognitive function and motor control.
| Synonyms | 5-(1H-indazol-5-yl)-3-[4-[(3,4,5-trimethoxyphenyl)methoxy]phenyl]-1,2,4-oxadiazole |
| Molecular Formula | C25H22N4O5 |
| Purity | ≥95% |
| IUPAC Name | 5-(1H-indazol-5-yl)-3-[4-[(3,4,5-trimethoxyphenyl)methoxy]phenyl]-1,2,4-oxadiazole |
| InChI | InChI=1S/C25H22N4O5/c1-30-21-10-15(11-22(31-2)23(21)32-3)14-33-19-7-4-16(5-8-19)24-27-25(34-29-24)17-6-9-20-18(12-17)13-26-28-20/h4-13H,14H2,1-3H3,(H,26,28) |
| InChIKey | MMVVUYZEFSZMKK-UHFFFAOYSA-N |
| SMILES | COC1=CC(=CC(=C1OC)OC)COC2=CC=C(C=C2)C3=NOC(=N3)C4=CC5=C(C=C4)NN=C5 |
